Jonathan Stoehr, MD, PhD
Disclosures: NO DISCLOSURE
1987-1991

 

Jonathan P. Stoehr, M.D., Ph.D.

1100 Ninth Ave. X8-ENSeattle, WA98101 jonathan.stoehr@vmmc.org

 

Curriculum Vitae

Employment / Professional Activities

  • 7/2012-present              Physician, Endocrinologist
    Medical Director – Nutrition Center of Excellence
    Virginia Mason Medical Center, Seattle, WA
    Division of Endocrinology, Diabetes, and Metabolism
  • 6/2008-6/2009              Clinical Instructor and Staff attending Physician,
    Yale School of Medicine and Yale New Haven Hospital, CT.
  • 5/2010-6/2012              Hospitalist Internal Medicine, Hematology/Oncology/Bone Marrow Transplant service, Oregon Health & Science University, Portland, OR (moonlighting activity)
  • 4/2010-4/2011              Internal Medicine, Kaiser Permanente Northwest, Portland, OR (moonlighting activity)
  • 12/2006-6/09              Hospitalist Internal Medicine, YNHH Medical Services, New Haven, CT (moonlighting activity)

Education / Postgraduate Medical Training

  • 7/2009-6/2012              Fellow, Endocrinology, Diabetes and Metabolism.
    Oregon Health & Science University.  Portland, OR.
  • 10/2010              Preceptorship in Endocrinology, Diabetes and Metabolism. 
    National Institutes of Health, Bethesda, MD.
  • 7/2007-6/2008              Chief Medical Resident,
    Yale School of Medicine and Yale New Haven Hospital, CT. 
  • 6/2004-6/2007              Internship and Residency, Internal Medicine (Traditional). 
    Yale New Haven Hospital, CT.
  • 8/1995-5/2004              Medical Scientist Training Program,
    University of Wisconsin Medical School, Madison, WI
    Awarded Ph.D. in Cellular and Molecular Biology in June 2002
    Awarded M.D. in May 2004. 
    Ph.D. thesis entitled “A genetic dissection of obesity and type 2 diabetes mellitus in the mouse.” 
  • 8/1991-6/1995              Massachusetts Institute of Technology, Cambridge, MA
    Awarded S.B. in Biology (with minor in Chemistry) in June 1995.

Licensure / Certification

  • Washington Medical License, Exp 4/17/2017
  • Oregon Medical License, Unlimited, exp 12/31/2011 (relocation)
  • NPI #1548476872
  • Board-Certified, American Board of Internal Medicine (Endocrinology).  Renewal 2024.
  • Board-Certified, American Board of Internal Medicine.  Renewal 2018.
  • Personal Federal DEA: Schedules 2, 2N, 3, 3N, 4, 5 (Exp Feb 2019)
  • Connecticut Medical License (expired due to relocation)
  • Connecticut Controlled Substance Registration (expired due to relocation)

Peer-reviewed Publications

  • Bhatnagar S, Oler AT, Rabaglia ME, Stapleton DS, Schueler KL … Stoehr JP, et al. Positional Cloning of a Type 2 Diabetes Quantitative Trait Locus; Tomosyn-2, a Negative Regulator of Insulin Secretion. PLoS Genet. 2011 Oct; 7(10): e1002323.
  • Clee SM, Yandell BS, Schueler KL, Stoehr JP, Rabaglia ME, Kabara EA, Klass DM, Lan H, Gray-Keller MP, Boronenkov I, Raines SM, Raess PW, Flowers MT, Attie AD. Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus.  Nat Genet. 2006 Jun; 38(6):688-93.  PMID: 16682971
  • Stoehr JP, Byers JE, Clee SM, Lan H, Boronenkov I, Schueler KL, Yandell BS, Attie AD.  Identification of major quantitative trait loci controlling body weight variation in ob/ob mice.  Diabetes. 2004 Jan; 53(1):245-9.  PMID: 14693723
  • Lan H, Stoehr JP, Nadler ST, Schueler KL, Yandell BS, Attie AD.  Dimension reduction for mapping mRNA abundance as quantitative traits.  Genetics. 2003 Aug; 164(4): 1607-14. PMID: 12930764
  • Lan H, Rabaglia ME, Stoehr JP, Nadler ST, Schueler KL, Zou F, Yandell BS, Attie AD.  Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility.  Diabetes. 2003 Mar; 52(3): 688-700.  PMID: 12606510
  • Attie AD, Krauss RM, Gray-Keller MP, Brownlie A, Miyazaki M, Kastelein JJ, Lusis AJ, Stalenhoef AF, Stoehr JP, Hayden MR, Ntambi JM.  Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia.  J Lipid Res. 2002 Nov; 43(11): 1899-907.  PMID: 12401889
  • Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM, Attie AD.  Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.  Proc Natl Acad Sci U S A. 2002 Aug 20; 99(17): 11482-6.  PMID: 12177411
  • Nadler ST, Stoehr JP, Rabaglia ME, Schueler KL, Birnbaum MJ, Attie AD.  Normal Akt/PKB with reduced PI3K activation in insulin-resistant mice.  Am J Physiol Endocrinol Metab. 2001 Dec; 281(6): E1249-54.  PMID: 11701440
  • Stoehr JP, Nadler ST, Schueler KL, Rabaglia ME, Yandell BS, Metz SA, Attie AD.  Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci.  Diabetes. 2000 Nov; 49(11): 1946-54.  PMID: 11078464
  • Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, Attie AD.  The expression of adipogenic genes is decreased in obesity and diabetes mellitus.  Proc Natl Acad Sci U S A. 2000 Oct 10; 97(21): 11371-6.  PMID: 11027337

Professional Memberships

  • Member, The Endocrine Society
  • Member, Oregon Medical Association

Medical Facility Credentialing

  • Staff admitting privileges, Virginia Mason Medical Center, Seattle, WA.  July 2012.
  • Staff admitting privileges, Kaiser Sunnyside Hospital, Portland, OR. March 2010-March 2012 CT (lapsed, relocation).
  • Staff admitting privileges, Yale New Haven Hospital, New Haven, CT (lapsed, relocation)
  • Staff admitting privileges, West Haven VA Medical Center, West Haven, CT (lapsed, relocation)

Teaching Activities

  • Small-group leader, Endocrine Pathophysiology course for 2nd year Medical Students, Oregon Health & Science University, Portland, OR.  February 2010, January 2011, December 2011.
  • Small-group leader, Cardiovascular Pathophysiology course for 2nd year Medical Students, Oregon Health & Science University, Portland, OR.  September 2010.
  • Clinical Instructor, Yale University School of Medicine, 2007-2009.
  • Tutor, Physical Diagnosis course for 1st and 2nd year Medical Students.  Yale University School of Medicine, 2008-2009.
  • Teaching assistant, Biochemistry 660, under professor Marv Wickens, UW Madison.
  • Teaching assistant, Chemistry 507, under Professors John Essigmann and Joanne Stubbe, MIT.

Professional Honors / Awards

  • Top Ten Teaching Faculty.  Virginia Mason Medical Center, Seattle, WA, 2013, 2014, 2015
  • Hugh Dwyer award (given to outstanding Chief Resident at Yale New Haven Hospital).  Awarded April 2008.

Published Case Reports

  • Stoehr, JP; Duell, PB.  Undetected Hypoglycemia in a Severely Anemic Jehovah’s Witness.  Endo Trends 18(1): 13-14, 2011.

CME-Accredited Oral Presentations

  • Virginia Mason Medical Center Primary Care Symposium, Feb 2016.
    The most common condition of all: Obesity for Primary Care Providers
  • American College of Physicians, Washington Chapter annual meeting, 2015.
    “An update on the medical management of obesity”
  • American Society of Bariatric and Metabolic Surgery – Seattle Chapter – Journal Club
    “Medical Complications of Bariatric Surgery”
  • Virginia Mason Medical Center Primary Care Symposium, Feb 2015.
    “An update on the medical management of obesity”
  • Virginia Mason Medical Center Primary Care Symposium, Jan 2014.
    “An update on the medical management of obesity”
  • Alaska Native Tribal Health Consortium, Symposium on Diabetes.  Anchorage, AK, Dec 2013.  “An update on the pharmacotherapy of type 2 diabetes”
  • Medical Grand Rounds, Virginia Mason Medical Center, Seattle, WA.  May 2013
    “Mountain or Molehill: Advances in the Pharmacotherapy of Obesity”
  • Visiting Faculty, Yale 3nd Symposium on Medical and Surgical Management of Obesity.  New Haven, CT. April 5, 2013.  “Current and emerging medical treatments for obesity.”
  • Visiting Faculty, Winter Meetings of Alaska Family Medicine Association
    Girdwood, AK.  March 2013. “Diabetes Type 2: What’s New”
  • Visiting Faculty, Management of the Diabetic Patient
    Virginia Mason Medical Center, Seattle, WA.  February 2013
    “Review of Outpatient Management of Diabetes”
  • Faculty, Washington Association of Physician Assistants Winter Meeting
    Seattle, WA.  January 2013. “Review of Outpatient Management of Diabetes,”
    “Review of Endocrinology”
  • Faculty, Challenges and Controversies in Primary Care
    Virginia Mason Medical Center, Seattle, WA.  May 2012
    “Diabetes Type 2: What’s New”
  • Visiting Faculty, Yale 2nd Symposium on Medical and Surgical Management of Obesity.  New Haven, CT. April 15, 2011.  “Current and emerging medical treatments for obesity.”
  • Endocrinology Grand Rounds, Oregon Health & Science University.  April 18, 2011.  “Current and emerging medical treatments for obesity.”
  • Visiting Faculty, Yale Symposium on Medical and Surgical Management of Obesity.  New Haven, CT. April 10, 2010.  “An update on the emerging medical therapies for obesity.”
  • Endocrinology Grand Rounds, Oregon Health & Science University.  May 5, 2010.  “An update on the emerging medical therapies for obesity.”
  • Medical Grand Rounds, Yale University School of Medicine.  New Haven, CT. Dec 13, 2007.  “Two patients with dysmetabolism: why do only some obese patients develop diabetes?”

Other Oral Presentations

  • Keynote Student Address, 2nd MSTP all-campus symposium.  April 2001.
  • Seminar, Obesity Study Group.  February 2001.
  • MSTP Seminar series, October 1997.

Conferences / Poster Presentations

  • Keystone Symposium on Obesity and Regulation of Energy Homeostasis.  Taos, NM.  Mar 2001.
  • American Diabetes Association, 2nd Conference on the Genetics of Diabetes.  San Jose, CA.  Oct 1999.
  • Steenbock Symposium on Obesity and AdipogenesisMadison, WI.  June 2000.
  • Frontiers in Genomics Symposium III.  Madison, WIAugust 1999.
  • American Diabetes Association Scientific Sessions.  Chicago, IL.  June 1998.
  • MSTP All-Campus Symposia.  Madison, WI.  1998-2003.
  • 12th National MD/PhD Student Conference.  Aspen, CO.  July 1997.
  • Interdepartmental Graduate Program in Nutritional Sciences Poster Session, Madison, WI.  March 2002.

Intellectual Property

  • Attie AD, Stoehr JP, Schueler K, Clee SM: Type 2 diabetes susceptibility genes. Wisconsin Alumni Res Found July 2005: EP1554397
  • Ntambi JM, Attie AD, Miyazaki M, Stoehr JP: Methods for Reducing Body Fat and Increasing Lean Body Mass by Reducing Stearoyl-COA Desaturase 1 Activity. September 2009: US 20090221677

Extra-Curricular Activities / Leadership

  • Chief Medical Resident, Yale New Haven Hospital, 2007-2008.
  • Student Leader, Medical Scientist Training Program, 1999-2000.
  • MSTP Admissions Committee member, 1999-2000 and 2000-2001.
  • Medical Student Demonstration Program.  1995-1996.